Direct oral anticoagulant secondary prophylaxis vs vitamin K antagonist secondary prophylaxis
Health related quality of life · patients with active cancer with venous thromboembolism
1 finding from 1 review
- Anticoagulation for the long‐term treatment of venous thromboembolism in people with cancer 2018 · Cochrane Headline outcomes onlyno estimate extracted1 study · 8485 participantsModerate